Recruiting
Early Phase 1

Tocilizumab in Children With ACP

Sponsor:

University of Colorado, Denver

Code:

NCT03970226

Conditions

Adamantinomatous Craniopharyngioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Tocilizumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by University of Colorado, Denver on 2025-03-25.